|
1）厚生労働省．平成24年国民健康・栄養調査結果の報告．2013
|
|
|
|
|
2）下方浩史，安藤富士子．疫学研究からのサルコペニアとそのリスク．日老医誌．2012; 49: 721-5
|
|
|
|
|
3）Morley JF, Baumgartner RN, Roubenoff R, et al. Sarcopenia. J Lab Clin Med. 2001; 137: 231-43
|
|
|
|
|
|
4）Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39: 412-23
|
|
|
|
|
|
5）Ｄelmonico MJ, Harris TB, Lee JS, et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc. 2007; 55: 769-74
|
|
|
|
|
|
6）Park SW, Goodpaster BH, Strotmeyer ES, et al. Decreased muscle strength and quality in older adults with type 2 diabetes: The health, aging, and body composition study. Diabetes. 2006; 55: 1813-8
|
|
|
|
|
|
7）Gougeon R, Styhler K, Morais JA, et al. Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes. Diabetes Care. 2000; 23: 1-8
|
|
|
|
|
|
8）Visser M, Pahor M, Taaffe DR, et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women. J Gerontol Biol Sci. 2002; 57: 326-32
|
|
|
|
|
|
9）Schragaer MA, Metter EJ, Simonsick E, et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol. 2007; 102: 919-25
|
|
|
|
|
|
10）Andersn H, Poulsen PL, Mogensen CE, et al. Isokinetic muscle strength in long-term IDDM patients in relation to diabetic complications. Diabetes. 1996; 45: 440-5
|
|
|
|
|
|
11）American Diabetes Association. Standards of medical care in diabetes--2014. Diabetes Care. 2014; 37(Suppl1): S14-S80
|
|
|
|
|
|
12）International diabetes federation: Glucose control management and targets. In: Managing older people with Type2 diabetes. ―Global guideline. 2014. p.30-6
|
|
|
|
|
|
13）Gispen WH, Biessels GJ. Cognition and synaptic plasticity in diabetic mellitus. Trends Neurosci. 2000; 23: 542-9
|
|
|
|
|
|
14）Biessels GJ, Staekenborg S, Brunner E, et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006; 5: 64-74
|
|
|
|
|
|
15）Clegg A, Young J, Iliffe S, et al. Frailty in elderly people. Lancet. 2013; 381: 752-62
|
|
|
|
|
|
16）Bandeen-Roche K, Xue QL, Ferrucci L, et al. Phenotype of frailty: characterization in the womenʼs health and aging studies. J Gerontol A Biol Sci Med. 2006; 61: 262-6
|
|
|
|
|
|
17）Sternberg SA, Wershof Schwarts A, Karunanthan S, et al. The identification of frailty: a systematic literature review. J Am Geriatr Soc. 2011; 59: 2129-38
|
|
|
|
|
|
18）Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults: A consensus report. J Am Geriatr Soc. 2012; 60: 2129-38
|
|
|
|
|
|
19）Araki A, Iimuro S, Sakurai T, et al. Long-term multiple risk factor interventions in Japanese elderly diabetic patients. Geriatr Gerontol Int. 2012; 12(suppl1): 7-28
|
|
|
|
|
|
20）Umegaki H, Iimuro S, Shinozaki T, et al. Risk factors associated with cognitive decline in the elderly with type 2 diabetes: Pooled logistic analysis of a 6-year observation in the Japanese elderly diabetes intervention trial. Geriatr Gerontol Int. 2012; 12(suppl1): 110-6
|
|
|
|
|
|
21）Ito H. Preface. Geriatr Gerontol Int. 2012; 12(suppl1): 5
|
|
|
|
|